Stay updated on Regorafenib Pembrolizumab CRC Clinical Trial
Sign up to get notified when there's something new on the Regorafenib Pembrolizumab CRC Clinical Trial page.

Latest updates to the Regorafenib Pembrolizumab CRC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedRevision on the page updates from v3.4.0 to v3.4.1 with no visible changes to the study content or essential page sections. The update appears to be an internal site version change rather than alterations to study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedAdded: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0; removed: Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now shows Revision: v3.3.4, replacing Revision: v3.3.3. This is a minor metadata update and does not affect study content or usability; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page introduces a new Locations section with California and Florida, replacing the former California Locations and Florida Locations entries; the revision version updated from v3.3.2 to v3.3.3.SummaryDifference0.3%

- Check92 days agoChange DetectedAdded Revision: v3.3.2 and removed Revision: v3.2.0 from the page's revision history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Regorafenib Pembrolizumab CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Regorafenib Pembrolizumab CRC Clinical Trial page.